The PTEN-induced putative kinase protein 1 (PINK1) and ubiquitin (UB) ligase PARKIN direct damaged mitochondria for mitophagy. PINK1 promotes PARKIN recruitment to the mitochondrial outer membrane (MOM) for ubiquitylation of MOM proteins with canonical and noncanonical UB chains. PINK1 phosphorylates both Ser65 (S65) in the UB-like domain of PARKIN and the conserved Ser in UB itself, but the temporal sequence and relative importance of these events during PARKIN activation and mitochondria quality control remain poorly understood. Using "UB
The PTEN-induced putative kinase protein 1 (PINK1) and ubiquitin (UB) ligase PARKIN direct damaged mitochondria for mitophagy. PINK1 promotes PARKIN recruitment to the mitochondrial outer membrane (MOM) for ubiquitylation of MOM proteins with canonical and noncanonical UB chains. PINK1 phosphorylates both Ser65 (S65) in the UB-like domain of PARKIN and the conserved Ser in UB itself, but the temporal sequence and relative importance of these events during PARKIN activation and mitochondria quality control remain poorly understood. Using "UB
S65A
-replacement," we find that PARKIN phosphorylation and activation, and ubiquitylation of Lys residues on a cohort of MOM proteins, occur similarly irrespective of the ability of the UB-replacement to be phosphorylated on S65. In contrast, polyubiquitin (poly-UB) chain synthesis, PARKIN retention on the MOM, and mitophagy are reduced in UB S65A -replacement cells. Analogous experiments examining roles of individual UB chain linkage types revealed the importance of K6 and K63 chain linkages in mitophagy, but phosphorylation of K63 chains by PINK1 did not enhance binding to candidate mitophagy receptors optineurin (OPTN), sequestosome-1 (p62), and nuclear dot protein 52 (NDP52) in vitro. Parallel reaction monitoring proteomics of total mitochondria revealed the absence of p-S65-UB when PARKIN cannot build UB chains, and <0.16% of the monomeric UB pool underwent S65 phosphorylation upon mitochondrial damage. Combining p-S65-UB and p-S65-PARKIN in vitro showed accelerated transfer of nonphosphorylated UB to PARKIN itself, its substrate mitochondrial Rho GTPase (MIRO), and UB. Our data further define a feed-forward mitochondrial ubiquitylation pathway involving PARKIN activation upon phosphorylation, UB chain synthesis on the MOM, UB chain phosphorylation, and further PARKIN recruitment and enzymatic amplification via binding to phosphorylated UB chains.
he RING-Between-RING ubiquitin (UB) ligase PARKIN and the PTEN-induced putative kinase protein 1 (PINK1), both of which are mutated in Parkinson's disease, promote ubiquitylation of numerous outer membrane proteins on damaged mitochondria, which facilitates mitophagy (1) . When mitochondria are healthy, cytoplasmic PARKIN is thought to be in an unphosphorylated and auto-inhibited state (2) (3) (4) (5) (6) . Upon mitochondrial damage, PINK1 is stabilized on the mitochondrial outer membrane (MOM) and promotes phosphorylation of both Ser65 (S65) on PARKIN's UB-like (UBL) domain and the conserved S65 residue in UB itself, which is 62% similar to PARKIN's UBL (1, (7) (8) (9) (10) (11) (12) (13) (14) . PARKIN is also retained on the mitochondrial surface and ubiquitylates numerous MOM proteins through the formation of both canonical and noncanonical UB chains. The order of events, as well as the precise roles of UB and PARKIN phosphorylation, is poorly defined, and multiple models have been proposed. All models agree that PARKIN activation reverses auto-inhibition but differ in the mechanism and role of p-S65-UB (8, (11) (12) (13) (14) (15) . In one model, binding of monomeric p-S65-UB to unphosphorylated PARKIN activates its UB ligase activity in vitro and promotes MOM ubiquitylation in vivo (11, 13, 14) . Additionally, overexpression of UB S65E/D mutants as mimetics of p-S65-UB in cells has been reported to activate PARKIN (13) (14) (15) . However, these studies have differed as to the relative importance of PARKIN and UB phosphorylation on pathway activation. In an alternative model, PINK1 initially phosphorylates a pool of PARKIN on S65 without a requirement for retention of PARKIN on mitochondria, resulting in PARKINdependent ubiquitylation of MOM proteins (12, 13, 15) . Newly synthesized UB chains are then phosphorylated by PINK1, facilitating recruitment of PARKIN through its p-S65-UB binding ability, resulting in both further PARKIN recruitment and additional MOM ubiquitylation (12) . Although PARKIN S65 phosphorylation increases its affinity for p-S65-UB by 20-fold (12) , phospho-UB on the MOM could potentially serve to recruit pools of both phosphorylated and unphosphorylated PARKIN.
Dissecting roles of UB and PARKIN phosphorylation must take into account the complexity inherent in this system, where UB (i) is transferred between multiple active sites involving the UB-conjugating enzyme UBCH7 and PARKIN, (ii) is linked to primary sites on MOM proteins, (iii) is phosphorylated by PINK1 to generate forms recognized by PARKIN itself, and (iv) is also recognized by UB receptors that promote mitophagy.
Significance
PINK1 protein kinase and PARKIN UB ligase are mutated in inherited forms of Parkinson's disease and several cancers. Thus, it is of great significance to understand normal functions that could be disrupted in disease. A role for PARKIN and PINK1 is in mediating autophagy of damaged mitochondria (mitophagy) through polyubiquitylation of numerous mitochondrial outer membrane proteins in a reaction that involves phosphorylation of both PARKIN and ubiquitin (UB) by PINK1. The mechanism remains unclear, however, due to challenges in defining individual steps in the pathway. Here, we use a UB replacement system to elucidate steps in the pathway that require PARKIN and/or UB phosphorylation by PINK1 and provide evidence of a PINK1-and UB-driven feed-forward mechanism important for efficient mitochondrial ubiquitylation and mitophagy.
PARKIN itself has a UBL domain with many similarities to UB, including being phosphorylated on the conserved S65. This system is made more complex by the fact that tools for studying phosphorylation of UB are limited largely to overexpression of phosphomimetics in vivo (13) (14) (15) . However, as demonstrated here, neither UB nor PARKIN phosphomimetics faithfully mimic the biochemical activities of phosphorylated PARKIN and UB in vitro, raising questions as to the in vivo roles of PINK1-dependent phosphorylation on PARKIN and/or UB deduced using these approaches.
Here, we used a UB-replacement strategy (16) to deplete all four mRNAs encoding UB in cultured cells while expressing UB S65A or UB mutants lacking individual Lys residues involved in chain assembly, thereby allowing an assessment of the role of UB phosphorylation and individual chain linkage types in PARKIN activation, MOM protein ubiquitylation, PARKIN retention on mitochondria, and mitophagy. Moreover, we developed in vitro pulse-chase and multiple-turnover assays to examine the role of p-S65-UB in individual steps in UB transfer by PARKIN. These studies rationalize many previous observations (10) (11) (12) (13) (14) (15) 17) and provide further insight into how phosphorylation of both UB and PARKIN promotes a "feed-forward" mechanism controlling mitochondrial ubiquitylation and mitophagy.
Results and Discussion S65D/E Does Not Mimic S65 Phosphorylation in UB or PARKIN. Previous efforts to define roles of phosphorylation of UB S65 in mammalian cells relied on overexpressed UB S65D/E or PARKIN S65D/E mutants (13) (14) (15) . We found that although p-S65-UB robustly activated UB chain synthesis by unphosphorylated PARKIN in the presence of unphosphorylated UB, as reported previously (11) (12) (13) (14) 17) , UB S65D or UB S65E did not ( Fig. 1A and Fig. S1A ). Likewise, PARKIN stoichiometrically phosphorylated on S65 (p-WT PARKIN) displayed robust UB chain synthesis activity as described previously (12) , whereas PARKIN S65D or PARKIN
S65E
did not (Fig. 1B and Fig. S1C ). As with p-S65-UB, UB S65D and UB S65E were used poorly for chain synthesis by p-WT PARKIN, as seen previously (12, 17) (Fig. S1B ). These data indicate that UB and PARKIN S65D/E mutants do not behave as true phosphomimetics in biochemical assays measuring PARKIN UB chain assembly activity.
UB-Replacement Reveals Requirement for PINK1-Dependent UB Phosphorylation in Mitochondrial Polyubiquitylation in Vivo. To test roles of UB phosphorylation directly in vivo, we used a UBreplacement strategy in U2OS cells (16) , wherein all endogenous copies of UB are depleted by doxycycline (DOX)-inducible RNAi while simultaneously expressing shRNA-resistant UB WT and UB S65A fused to the N terminus of ribosomal proteins L40 and S27a from a DOX-responsive promoter (Fig. 1C) . Immunoblotting (Fig. S1D ) of extracts demonstrated similar levels of UB WT and UB S65A proteins in both monomeric and conjugated forms after DOX induction for 5 d, and UB-absolute quantification (AQUA) proteomics revealed ∼11% endogenous UB remaining in UB S65A -replacement cells (Fig. S1E) , comparable to the level of endogenous UB seen previously with other UB mutants (16 . These cells were left untreated or depolarized with antimycin A and oligomycin A (AO) over a 2-h time course and ubiquitylation of two known PARKIN targets, MFN2 and CISD1, examined by immunoblotting of whole-cell extracts (Fig. 1D) or after enrichment of ubiquitylated mitochondrial proteins with immobilized haloalkane dehalogenase (HALO)-tagged-UBA UBQLN1 (Fig. 1E) , which preferentially binds all forms of polyubiquitin (poly-UB) chains. In whole-cell extracts, MFN2 monoubiquitylation was prominent at 30 min after depolarization, including in UB S65A -replacement cells. However, over time, this replacement cells expressing WT, S65A, or catalytic Cys-to-Ser PARKIN were depolarized for the indicated times with AO, and whole-cell extracts (WCE) were subjected to immunoblotting (IB) with α-MFN2 and α-CISD1 antibodies. PARKIN and proliferating cell nuclear antigen (PCNA) levels were determined as loading controls. (E) Same as D, except polyubiquitylated proteins were purified using immobilized HALO-UBA
UBQNL1
. After washing, proteins were subjected to immunoblotting with α-MFN2 and α-CISD1. PD, pull-down.
product was converted to more slowly migrating species in UB WTreplacement cells, shown clearly as polyubiquitylated species in the HALO-UBA UBQLN1 -enriched samples ( Fig. 1 D and E) . In contrast, in UB S65A -replacement cells, monoubiquitylated MFN2 is maintained at 2 h, but the extent of MFN2 polyubiquitylation was greatly reduced (Fig. 1 D and E) . Similar results were seen with CISD1, although monoubiquitylated forms were kinetically delayed ( Fig. 1 D and E) . UB WT -replacement cells expressing PARKIN S65A or PARKIN C431S displayed no or very low activity toward MFN2 and CISD1, as seen previously (12) ( Fig. 1 D and E) . We infer that UB S65 -phosphorylation promotes UB chain synthesis on PARKIN's substrates.
Correlation Between Defects in PARKIN-Mediated UB Chain Synthesis and Absence of UB Phosphorylation on Depolarized Mitochondria.
We used UB-AQUA (12) to assess total UB, chain linkage types, and the stoichiometry of UB phosphorylation on UB chains purified from mitochondria ( Fig. 2A and Fig. S1G ) quantitatively, although we were unable to quantify K63 linkages derived from the inducibly expressed UB S65A mutant in UB S65A -replacement cells due to the replacement of Ser by Ala. As expected (12) , depolarization led to an increase in the total abundance of UB associated with depolarized mitochondria in cells expressing PARKIN WT (∼1,600 fmol) relative to nondepolarized cells or to cells expressing PARKIN C431S ( Fig. 2A) . K6, K11, K48, and K63 UB chains were found (Fig. S1G ), as seen in HeLa cells (12) (3, 12, 18, 19) can occur in the absence of PARKIN-dependent UB-chain assembly on depolarized mitochondria (12) . Moreover, S65 phosphorylation in PARKIN activates the ability of C431 to react with UB-vinyl sulfone in vitro (12) . We found that GFP-PARKIN C431S in either UB WT -or UB S65A -replacement cells formed an oxy-ester with UB with equivalent efficiency upon depolarization (Fig. S1H) , and the extent of S65 PARKIN phosphorylation was equivalent with GFP-PARKIN WT as measured by AQUA proteomics (Fig. 2C) . In response to depolarization, we identified 101 primary di-Gly sites in 40 MOM proteins in UB WT -replacement cells ( Fig. S1J and Dataset S1), in agreement with prior reports (20) (21) (22) . Only 10 di-Gly sites were identified without depolarization, and only five were found in control UB WT -replacement cells expressing PARKIN C431S (Dataset S1). At least one primary ubiquitylation site was detected in all but 12 substrates in UB S65A -replacement cells, and those ubiquitylation sites not detected in UB S65A -replacement cells were present in UB WT -replacement cells at only one spectral count (Dataset S1). Moreover, the number of spectral counts for well-characterized substrates was generally comparable (Fig. 2D) , and di-Gly-containing peptides were isolated using α-di-Gly antibodies before analysis by liquid chromatography/tandem MS. The numbers of spectral counts identified for CISD1, HK1, and MFN2 are shown. and GFP-PARKIN C431S displayed very low to no mitochondrial recruitment ( Fig. 3A and Fig. S2B ).
We next examined mitophagy (as measured by immunofluorescence with α-TOMM20) in UB-replacement cells (Fig. 3B ) by quantifying the percentages of cells with nonaggregated mitochondria, aggregated mitochondria, and cleared mitochondria (Fig. 3B) (Fig. S3D) . Involvement of K6 and K63 chains in mitophagy was also reported recently based on overexpression of UB mutants (22) .
For K63 UB chains, one obvious potential role would be recognition by autophagy receptors, including optineurin (OPTN) and sequestosome-1 (p62), which have been implicated in promoting mitochondrial clustering and/or mitophagy and shown to bind K63 chains (23) (24) (25) . Given the proximity of S65 and K63 in UB (17), we asked whether UB S65 phosphorylation in K63 UB chains (with a stoichiometry of 0.52) affects receptor interactions. GST-OPTN associated efficiently with K63 chains but not with K48 or monoubiquitin (Fig. S3E ), and this association was reduced upon chain phosphorylation ( Fig. S3 E, H, and I). Analogous experiments with nuclear dot protein 52 (NDP52) and p62 gave similar results (Fig. S3 F and G). These data suggest that mechanisms other than direct recognition of phosphorylated K63 UB chains by these receptors may promote mitophagy.
p-S65-UB Promotes UB Transfer in Single-Turnover Assays. p-S65-UB binds to unphosphorylated PARKIN and promotes UB chain synthesis in vitro (12, 13, 17) . To test whether other known phosphorylated forms of UB (p-S20 and p-S57) are also capable of activating UB chain synthesis by PARKIN, we synthesized these three forms of p-UB using an Escherichia coli phosphoserine expression system (26) . Only p-S65-UB activated unphosphorylated PARKIN ( Fig. S4 A and B) , and this activation required the classical UB "hydrophobic patch," because p-S65-UB I44A failed to activate (Fig. S4A ). In contrast, p-S65-UB inhibits the ability of stoichiometrically phosphorylated p-WT PARKIN to build chains with unphosphorylated UB, potentially due to competition with UB in the conjugation cascade. Indeed, p-S65-UB is used very poorly by p-WT PARKIN to build chains when present as the only source of conjugatable UB (12, 17) (Fig. S1B) .
To rationalize the various findings with p-S65-UB (10-14, 17) (Figs. S1 A and B and S4 A and B), we considered that C-terminally blocked, nonconjugatable p-S65-UB could mimic forms of p-S65-UB linked to mitochondrial proteins, whereas p-S65-UB with a free C terminus could engage in the catalytic cycle with inhibitory consequences. Indeed, we found that nonconjugatable p-S65-UB-6His not only fails to inhibit, but actually further stimulates, UB chain synthesis by p-WT PARKIN in vitro (Fig. 4A) . Time-course analysis of p-WT PARKIN activation in vitro using UB-AQUA demonstrated a 2,473-fold increase in chain assembly rate relative to unphosphorylated PARKIN, as seen previously (12), and adding p-S65-UB-6His increased this increase further to 4,398-fold (Fig. S4C) . Thus, binding of p-WT PARKIN to nonconjugatable p-S65-UB may serve to enhance catalysis further, in addition to having a potential tethering function.
To define functions of p-S65-UB further, we developed pulsechase assays that monitor transfer of fluorescently labeled Lys-free UB (UB F ) from UBCH7∼UB F to p-WT PARKIN itself (autoubiquitylation) or to either free unlabeled UB to form di-UB or the known mitochondrial PARKIN substrate mitochondrial Rho GTPase (MIRO) tagged with GST. Adding stoichiometric p-S65-UB to p-WT PARKIN greatly stimulated transfer from UBCH7∼UB to PARKIN (Fig. 4B and Fig. S4D ). Fifty percent of UBCH7∼UB F is discharged within 10 s in the presence of p-WT PARKIN and p-S65-UB, whereas this process takes 50 min in the absence of p-S65-UB (Fig. 4B and Fig. S4D ), suggesting that p-S65-UB could stimulate this step potentially by more than two orders of magnitude. This stimulation required PARKIN's active site Cys (Fig. S4E ) and the canonical RING binding residue (F63) in UBCH7 (Fig. S4F) . Very high concentrations of p-WT PARKIN were required to stimulate UBCH7∼UB discharge at a rate similar to the stoichiometric pWT-PARKIN·p-S65-UB complex (Fig. S4G) . Rate enhancements for transfer from UBCH7∼UB F to UB (di-UB synthesis) and GST-MIRO were also seen in pulse-chase and multiple-turnover assays (Fig. 4 C and D and  Fig. S4H ). Probing the mechanism further, we found that unphosphorylated PARKIN C431S failed to assemble a stable complex with UBCH7 C86K -UB iso as assessed by gel filtration (Fig. S4I) . In contrast, addition of p-S65-UB led to loss of free UBCH7 C86K -UB iso consistent with the formation of a stable PARKIN C431S ·UBCH7
C86K
-UB iso ·p-S65-UB complex (Fig. S4I ). Taken together, these data suggest that forms of p-S65-UB that cannot be used in chain assembly reactions, such as poly-p-S65-UB chains on mitochondria, are capable of further activating p-WT PARKIN beyond the activity it possesses by direct PINK1 phosphorylation, and that this process may occur, in part, by facilitating association with charged UBCH7.
Implications of UB S65 Phosphorylation for PARKIN Function. These studies provide further insight into a feed-forward mechanism underlying PARKIN activation by PINK1 (12) (Fig. 4E) . Replacement of UB with UB S65A has major effects on the assembly of poly-UB chains on damaged mitochondria, recruitment of PARKIN to mitochondria, and the efficiency of mitophagy. In contrast, PARKIN phosphorylation on S65 by PINK1, PARKIN activation, and primary ubiquitylation of MOM proteins all occur largely on schedule in UB S65A -replacement cells, which are defective in accumulation of p-S65-UB on the MOM. Although we cannot rule out a role for phosphorylation of residual UB in UB S65A -replacement cells, these results indicate a very profound role for UB phosphorylation in late steps of the pathway and, in particular, in the synthesis and subsequent phosphorylation of UB chains on mitochondria that appear to be central to the amplification mechanism (Fig. 4E) .
UB phosphomimetics have been used to address the mechanism of PARKIN activation, but we find that S65D/E mutants in UB and PARKIN poorly recapitulate PARKIN activation in vitro, and thus may be more appropriate for modeling loss of function upon phosphorylation rather than activation. Using PRM proteomics of total mitochondria, we confirmed our previous finding (12) that phosphorylation of UB on mitochondria requires depolarization-dependent chain synthesis by PARKIN (Fig. S1I ). This finding, together with the fact that PARKIN recruitment is defective in UB S65A -replacement cells, indicates that bulk recruitment and chain elongation occur downstream of initial PARKIN activation and primary ubiquitylation events (Fig. 4E, Middle) . Although our data suggest that initial PARKIN S65 phosphorylation occurs independent of MOM UB S65 phosphorylation, it is possible that an important aspect of the feed-forward mechanism is recruitment of a pool of unphosphorylated PARKIN to p-S65-UB on the MOM. This recruitment could serve two purposes (Fig. 4E , Left and Right). First, such recruitment could enhance MOM ubiquitylation through direct activation of PARKIN UB ligase activity, albeit with a lower specific activity than phosphorylated PARKIN (12) . Second, such recruitment could enhance phosphorylation of PARKIN S65 by increasing the proximity of PARKIN and PINK1.
An alternative model involves phosphorylation of free UB by PINK1, which could then bind and activate PARKIN (11, 13, 14) . We examined the levels of monomeric p-S65-UB in PINK1
+/+ and PINK1 −/− HeLa cells expressing PARKIN WT or PARKIN C431S with or without depolarization. We found a 0.163% increase in p-S65-UB in PARKIN WT cells after depolarization from its resting state of 0.189% relative to the total monomeric pool of UB, although we cannot rule out the possibility that a portion of this increase derives from damaged MOM UB chains, because a Fig. 4 . Additional element in PINK1-dependent feed-forward signaling: p-S65-UB activation of UB transfer from PARKIN to substrates. (A) Nonconjugatable form of p-S65-UB activates UB chain synthesis by p-WT PARKIN and is not inhibitory in vitro. p-WT or p-C431S PARKIN was incubated with either p-S65-UB or the indicated amount of p-S65-UB-6His, and mixtures were supplemented with ATP, E1, UBCH7, and UB to allow for chain assembly. After 30 min, reaction mixtures were subjected to immunoblotting with α-UB and α-PARKIN antibodies. (B) p-S65-UB greatly stimulates transfer of Lys-free UB from UBCH7 to PARKIN in single-turnover assays. UBCH7 was charged with E1, UB F , and ATP, and purified by gel filtration. UBCH7∼UB F was mixed with p-WT PARKIN in the presence or absence of p-S65-UB, and reactions were quenched at the indicated times postmixing. Reaction mixtures were separated by SDS/PAGE, and UB F was detected (Fig. S4D) . Loss of UBCH7∼UB F was plotted. (C) As in Fig. S4E , but chased in the presence of UB (300 μM) to allow di-UB synthesis to be monitored. (D) Nonconjugatable p-S65-UB promotes PARKIN-dependent transfer of UB to MIRO in multipleturnover assays. p-WT or p-C431S PARKIN was incubated with UB and GST-MIRO 180-581 in the presence of ATP, E1, and UBCH7, and reactions were quenched and subjected to SDS/PAGE and immunoblotting with α-UB, α-GST, or α-PARKIN at the indicated times. (E) Schematic of a unifying feedforward model for the PINK1-PARKIN pathway. (Middle) Mitochondrial damage leads to PARKIN recruitment to mitochondria (1) and its PINK1-dependent phosphorylation (2), resulting in the activation of its UB ligase activity. Because activated PARKIN promotes primary substrate ubiquitylation (3), this process increases the density of UB on mitochondria and provides a substrate for phosphorylation by PINK1 (4). We hypothesize that maximal UB amplification involves recruitment of phospho-PARKIN to phospho-UB chains through a direct interaction, and maximal chain synthesis reflects the fact that phospho-PARKIN has significantly higher specific activity than unphosphorylated PARKIN bound to phospho-UB. smaller increase (0.053%) was observed in PARKIN C431S (Fig.  S4J) . However, the finding that PARKIN S65A is not efficiently recruited to the MOM and cannot mount an efficient feed-forward response (12) (Figs. 1 D and E and 3A) indicates the absence of a prominent role for monomeric p-S65-UB in PARKIN activation, given that unphosphorylated PARKIN S65A is still activated by p-S65-UB in vitro (12) .
Signal amplification also may be manifested by binding of p-S65-UB chains to phosphorylated PARKIN, as indicated by increased rates of UB transfer from p-WT PARKIN to substrates and itself in single-turnover and multiple-turnover assays upon binding to nonconjugatable forms of p-S65-UB (Fig. 4E) . We speculate that the density of primary substrates, and conjugated UB molecules used as acceptors for chain synthesis, may have distinct properties that are reflected in the single-and multipleturnover assays reported here. Phosphorylation of PARKIN alone promotes opening of its active site for reaction with UB-vinyl sulfone (12), but both PARKIN phosphorylation and binding to p-S65-UB greatly enhance association with charged UBCH7 (Fig. S4I) . The biochemical basis for these activation steps remains to be determined.
These studies extend our understanding of a feed-forward mechanism (12) wherein PINK1-dependent phosphorylation of PARKIN promotes initial isopeptide bond formation between UB and Lys residues on MOM proteins and newly conjugated UB is then phosphorylated by PINK1 (Fig. 4E) . These events are hypothesized to promote PARKIN retention on damaged mitochondria as well as additional chain synthesis through both PARKIN localization and increased ubiquitylation activity. Amplification of UB density on mitochondria may promote mitophagy. Further work is necessary to determine whether primary substrate specificity is a component of the feed-forward mechanism. A key aspect of this model is supported by the finding that optimal binding of PARKIN to UB chains occurs when both PARKIN and UB are phosphorylated on S65 (K d of ∼20 nM) (12) , although the affinity of unphosphorylated PARKIN for p-S65-UB (∼370 nM) may also be sufficient to support recruitment as described above (12) . Additional studies are required to understand mechanisms by which UB chains and phosphorylation ultimately mediate mitophagy. Although the autophagy receptors OPTN and p62 bind K63-linked UB chains and are thought to direct mitochondrial aggregation and clearance (23, 25) , we find that substoichiometric phosphorylation of K63 chains reduces their in vitro binding to OPTN, p62, and NDP52 (Fig. S3 E-G) . We speculate that bias against phosphorylation of K63 chain linkages relative to other linkages in vivo (12) 
Materials and Methods
Full methods are provided in SI Materials and Methods. UB-replacement cells were produced as described (16) . Mitochondrial purification and UB-AQUA proteomics were performed as described (12) . Mitophagy in U2OS cells was performed 16-20 h after depolarization with antimycin A and OA by following α-TOMM20 staining by immunofluorescence. GFP-PARKIN translocation to mitochondria was determined by immunofluorescence after staining of depolarized cells with α-TOMM20 antibodies. Ubiquitylation assays were performed using multiple-turnover assays with the indicated concentrations of PARKIN, UB, p-S65-UB, and UBCH7. Single-turnover assays were performed with UBCH7∼UB F , wherein UB F was tagged with fluorescein and all Lys residues were preplaced with Arg. Reactions were monitored by gel electrophoresis followed by fluorescence detection. (75351) were from Sigma. Phos-Tag gels were from Wako Chemicals. GFP-trap_A was from Chromotek. Recombinant HA-UB-vinyl sulfone, E1 UB-activating enzyme, and UB-conjugating enzyme UBE2L3, as well as K48-linked (K48 [2] [3] [4] [5] [6] [7] ) and K63-linked (K63 [2] [3] [4] [5] [6] [7] ) UB oligomers were generously provided by Brad Brasher (Boston Biochem, Cambridge, MA).
Supporting Information
Cell Culture, Immunoblotting, and Mitochondrial Protein Isolation.
U2OS parental UB-replacement cells were generously provided by Z. James Chen (University of Texas Southwestern Medical Center, Dallas, TX). All UB-replacement cells were made as previously described (1) . Untagged or GFP-PARKIN was stably expressed in UB-replacement cells using a pLenti-Zeocin vector. Cells with low levels of untagged PARKIN were isolated by single-cell cloning, whereas those cells expressing GFP-PARKIN were isolated by fluorescence-activated cell sorting by selecting twice the lowest 5% of GFP expression. To induce protein expression, cells were treated with 2 μM DOX (renewed every 48 h) for 5 d unless stated otherwise to induce UB shRNA expression and expression of the shRNA-resistant replacement UB (WT, S65A, K6R, K11R, K48R, or K63R). Cells were either left untreated or depolarized with a mixture of antimycin A (10 μM) and OA (5 μM) for the indicated time period. At the indicated times, cells were washed twice with ice-cold PBS and lysed in lysis buffer [50 mM Tris·HCl (pH 7.5), 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 5 mM sodium pyrophosphate, 10 mM sodium 2-glycerol 1-phosphate, 1 mM sodium orthovanadate, 0.27 M sucrose, 1% (vol/vol) Nonidet P-40, 1 μg/mL leupeptin/ aprotinin, 0.5 mM 4(2-aminoethyl)benzenesulfonyl flouride (AEBSF)] to produce whole-cell extracts.
Crude mitochondria were purified after two washes in ice-cold PBS by scraping cells in PBS containing 200 mM chloroacetamide (3 mL per 15-cm dish). Cells were then collected and centrifuged at 450 × g for 5 min at 4°C. The cell pellet was resuspended in 5 mL (per 15-cm dish) of mitochondrial isolation buffer [MIB; 50 mM Tris·HCl (pH 7.5), 70 mM sucrose, 210 mM sorbitol, 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 5 mM sodium pyrophosphate, 10 mM sodium 2-glycerophosphate, 0.2 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, 1 μg/mL leupeptin/ aprotinin] plus 100 mM chloroacetamide and was centrifuged at 1,400 × g for 5 min at 4°C. The cell pellet was resuspended in 5 mL of MIB buffer plus 100 mM chloroacetamide and sonicated four times for 15 s at the lowest settings. Sample were spun for 10 min at 1,400 × g to remove unbroken cells/debris, and supernatant was collected; this supernatant corresponds to the "total protein" fraction, and was transferred into a round-bottomed tube before centrifugation for 10 min at 10,000 × g. Supernatant corresponding to the cytosolic fraction and the crude endoplasmic reticulum (ER) fraction was removed, and the pellet corresponding to the crude mitochondria fraction was resuspended in 10 mL of MIB buffer plus 100 mM chloroacetamide before centrifugation for 10 min at 9,000 × g. The mitochondrial pellet was washed two more times, and the pellet was then lysed in lysis buffer plus 100 mM chloroacetamide and 0.5 mM AEBSF.
Whole-cell extracts or mitochondrial extracts were sonicated and clarified by centrifugation (16,000 × g for 10 min at 4°C), and protein concentrations were determined by the Bradford assay. Cell extracts (25 μg) or mitochondrial extracts were separated by SDS/PAGE and transferred to PVDF membranes, and proteins were detected by immunoblotting.
p-S65 Measurement in Free Unanchored UB in HeLa Cells. PINK1 WT or KO HeLa Flp-In T-REx cell lines (Life Technologies) expressing various forms of PARKIN were generated as described before (2) . To induce protein expression, cells were treated with 0.5 μM DOX for 16 h to induce low levels of PARKIN proteins. Cells were either left untreated or depolarized with a mixture of antimycin A (10 μM) and OA (5 μM) for the indicated time period. At the indicated times, plates were washed twice with icecold PBS and lysed in lysis buffer [50 mM Tris·HCl (pH 7.5), 8 M urea, 1 mM EDTA, 50 mM NaF, 5 mM sodium pyrophosphate, 10 mM sodium 2-glycerol 1-phosphate, 1 mM sodium orthovanadate, 1 μg/mL aprotinin, 1 μg/mL leupeptin, 0.5 mM AEBSF, 200 mM chloroacetamide, phosphatase inhibitor mixture (Roche)] to produce whole-cell extracts. Whole-cell extracts were sonicated and clarified by centrifugation (16,000 × g for 10 min at 4°C) and filtered through 0.45 μ filters (Sartorius), and protein concentrations were determined by the Bradford assay. Proteins with a molecular mass between 3 and 10 kDa were separated from cell extracts (2 mg) using a 50-kDa molecular weight cutoff (MWCO) spin concentrator (Millipore), followed by 30-kDa and 10-kDa MWCO spin concentrators. During the isolation, lysates and flow-through were diluted when needed in 50 mM Tris·HCl (pH 7.5), 1 mM EDTA, 50 mM NaF, 5 mM sodium pyrophosphate, 10 mM sodium 2-glycerol 1-phosphate, 1 mM sodium orthovanadate, 1 μg/mL aprotinin, 1 μg/mL leupeptin, 0.5 mM AEBSF, and phosphatase inhibitor mixture. Final flow-through from the 10-kDa MWCO spin concentrator was concentrated using a 3-kDa MWCO spin concentrator, and samples were reduced [10 mM tris(2-carboxyethyl)phosphine (TCEP)], alkylated (20 mM chloroacetamide), and precipitated with 20% (vol/vol) TCA. TCA-precipitated proteins were then subject to the UB-AQUA/PRM proteomic workflow as described below.
Mitochondrial UB and Poly-UB Capture and Proteomics. Mitochondrially derived ubiquitylated proteins were purified using Halo-4× UBA UBQLN1 as described (2) . Briefly, whole-cell extracts (0.5 mg) or mitochondrial extracts (0.5 mg) that were lysed in lysis buffer containing 100 mM chloroacetamide were incubated at 4°C for 4 h or 16 h with 30-50 μL of Halo-4× UBA UBQLN1 beads (pack volume). Following four washes with lysis buffer containing 1 M NaCl and one final wash in 10 mM Tris (pH 8.0), proteins were released from Halo-4× UBA UBQLN1 beads using sample buffer before analysis by SDS/PAGE and immunoblotting or by 6 M guanidine HCL when analyzed by MS. For immunoblotting, samples were separated on 4-12% BisTris gradient gels. For MS, samples were subjected to reduction (10 mM TCEP) and alkylation (20 mM chloroacetamide) followed by TCA precipitation. Samples were digested overnight at 37°C with Lys-C and trypsin [in 100 mM tetraethylammonium bromide, 0.1% Rapigest (Waters Corporation), 10% (vol/vol) acetonitrile (ACN)]. Digests were acidified with an equal volume of 5% (vol/vol) formic acid (FA) to a pH of ∼2 for 30 min, dried down, resuspended in 5% (vol/vol) FA, and subjected to C18 StageTip (packed with Empore C18; 3M Corporation) desalting. Samples were analyzed by liquid chromatography (LC)/tandem MS or used for AQUA as described below.
UB-AQUA Proteomics. UB-AQUA was performed largely as described previously but with several modifications (2, 3) . A collection of 19 heavy-labeled reference peptides (2), each containing a single 13 C/ 15 N-labeled amino acid, was produced at Cell Signaling Technologies and quantified by amino acid analysis. UB-AQUA peptides from working stocks [in 5% (vol/vol) FA] were diluted into the digested sample [in 5% (vol/vol) FA] to be analyzed to an optimal final concentration predetermined for individual peptide such that each peptide's intensity would range between 10 6 and 10 8 . Samples and AQUA peptides were oxidized with 0.1% hydrogen peroxide for 30 min, subjected to C18 StageTip and resuspended in 5% (vol/vol) FA. Both in vitro and in vivo experiments were performed in triplicate and analyzed sequentially by LC/MS on an Exactive-Orbitrap mass spectrometer (Thermo Scientific) equipped with a Thermo Fisher nanospray source, a PAL HTC (ThermoScientific) autosampler for sample handling, and an Accela HPLC pump (ThermoScientific) for LC separations. Nanoliter flow rates across the column were achieved using a flow-split method. Peptides were separated on a 125-μm × 18-cm hand-pulled fused silica microcapillary column with a needle tip diameter of <10 μm and were packed with 3 μm , m/z range of 350-1,000, maximum ion time of 500 ms, and lock mass of 371.1012 m/z. LC/MS data analysis was performed using Pinpoint software (Thermo Fisher Scientific) with manual validation of peptide masses (2) . MS 1 intensities from Pinpoint were exported as a .CSV file for further analysis in Microsoft Excel and GraphPad Prism. Total UB was determined as the average of the total UB calculated for each individual locus, unless specified otherwise. In experiments using the UB replacement cells, the femtomole values of the AQUA peptides starting with Met1 of UB were multiplied by 2 to reflect the fact that half of the RNAi-resistant UB reexpressed under DOX treatment contains an N-terminal HA tag preventing the measurement of these peptides. For UB chain synthesis kinetics, data were further analyzed in Prism and linear regression analysis was performed to fit slopes with quantitative MS data. R 2 is the coefficient of determination, and the 95% confidence intervals are indicated by dotted lines (Fig. S4C) .
UB-AQUA/PRM Proteomics. Our MS data were collected using a Q Exactive mass spectrometer (Thermo Fisher Scientific) coupled with a Famos Autosampler (LC Packings) and an Accela600 LC pump (Thermo Fisher Scientific). Peptides were separated on a 100-μm i.d. microcapillary column packed with ∼0.5 cm of Magic C4 resin (5 μm, 100 Å; Michrom Bioresources) followed by ∼20 cm of Accucore C18 resin (2.6 μm, 150 Å; Thermo Fisher Scientific). Peptides were separated using a 30-min gradient of 7-30% acetonitrile in 0.125% FA with a flow rate of ∼300 nL·min , maximum injection time of 250 ms, and profile spectrum data type. This scan was followed by 12 targeted MS 2 scans selected from a scheduled inclusion list with a 5-min retention time window. Each targeted MS 2 scan consisted of high-energy collision dissociation (HCD) with the following parameters: resolution of 35,000, AGC of 1 × 10 6 , maximum injection time of 200 ms, isolation window of 1 Th, normalized collision energy (NCE) of 27, and profile spectrum data type. Raw files were searched, and precursor and fragment ions were quantified using Skyline version 3.1 (4). The UB-AQUA peptides used for quantitation were previously listed by Ordureau et al. (2) (Fig. S1G) . Data generated from Skyline were exported into an Excel spreadsheet and Prism for further analysis as previously described (2) .
Immunoprecipitation of PARKIN and p-S65-PARKIN Quantification.
Cells at 80% confluence expressing catalytically inactive GFP-PARKIN C431S mutant were treated with DOX (2 μg/mL renewed every 48 h) for 5 d and then treated with antimycin A (10 μM) and OA (5 μM) for 1 h. Cells from 2 × 15-cm dishes were washed twice with ice-cold PBS and lysed in 3 mL of lysis buffer supplemented with protease and phosphatase inhibitors. Whole-cell extracts were sonicated, clarified by centrifugation (16,000 × g for 10 min at 4°C), and filtered through 0.45-μm filters (Sartorius), and protein concentrations were determined by the Bradford assay. GFP-PARKIN from whole-cell extracts (10 mg) was affinity-purified with 10 μL of GFP-trap_A resin (Chromoteck) for 1 h at 4°C. Beads were washed three times with lysis buffer containing 500 mM NaCl and four times with 10 mM Tris (pH 8.0). Elution with 6 M guanidine HCL was performed twice (50 μL for 10 min), and eluates were combined, reduced (10 mM TCEP), and alkylated (20 mM chloroacetamide) and then precipitated with 20% TCA. TCA-precipitated proteins were then subject to the AQUA proteomic workflow. PARKIN phosphorylation was measured using AQUA proteomics as described (2) . Heavy-labeled reference peptides for S65-PARKIN were obtained from JPT Peptides Technologies (SpikeTides_TQL Proteotypic Peptides). S65-PARKIN AQUA peptides (nonphospho and phospho heavy peptide) were reduced (10 mM TCEP) and alkylated (20 mM chloroacetamide), dried down, and resuspended in 5% FA. The desired amount of AQUA peptide was mixed with a previously TCA-precipitated sample before Lys-C and trypsin enzymatic digestion (in 100 mM TEAB, 0.1% Rapigest, 10% ACN). Samples were then handled as previously described in the section on UB-AQUA samples (UB-AQUA/PRM Proteomics). MS 1 signal for both the cleaved and miscleaved forms of S65-peptide (NDWTVQNCDLDQQS-IVHIVQR and NDWTVQNCDLDQQSIVHIVQRPWR, respectively) was measured and monitored using Pinpoint software.
Mitophagy Assays. Each cell line was treated with DOX (2 μM renewed after 48 h) for 5 d and then treated with both antimycin A (10 μM) and OA (5 μM) as indicated. At the indicated time (16-20 h), cells were fixed with 4% paraformaldehyde, permeabilized with 0.2% Triton X-100, blocked with 1% BSA, and immunostained with α-TOMM20 antibody followed by Hoechst staining. All images were then collected with a Yokogawa CSU-X1 spinning disk confocal lens on a Nikon Ti-E inverted microscope equipped with a 100× Plan Apo N.A. 1.4 objective lens in the Nikon Imaging Center at Harvard Medical School. For quantification, ∼100 cells were counted based on the classification of nonaggregated mitochondria, aggregated mitochondria, and cleared mitochondria in biological triplicate.
Analysis of GFP-PARKIN Translocation. U2OS UB-replacement cell lines expressing GFP-PARKIN or the indicated mutants were treated on DOX (2 μM, renewed after 48 h) for 5 d, and cells were treated with both antimycin A (10 μM) and OA (5 μM). At the indicated time (45 min or 1 h), cells were fixed with 4% paraformaldehyde, permeabilized with 0.2% Triton X-100, blocked with 1% BSA, and immunostained with α-TOMM20 antibody followed by Hoechst staining. All images were then collected as described in the mitophagy assay. For quantification, ∼200 cells were counted to determine the percentage of cells containing mitochondria-localized PARKIN in biological triplicate.
Cell Proliferation Assay. Cell proliferation assays were performed using CCK-8 (Dojindo Molecular Technologies), which indirectly measures the levels of intracellular NADH and NADPH. Briefly, the same numbers of cells were plated in a 96-well plate in DMEM with 10% FBS in the presence and absence of DOX (2 μM) to induce depletion of endogenous UB and expression of the UB transgenes. At the indicated time, CCK-8 reagent was added to each well and incubated at 37°C with 5% CO 2 for 2 h, and the OD 450 was measured using a SpectraMax M5 instrument (Molecular Devices).
Protein Expression, Purification, and Phosphorylation. PARKIN purification and phosphorylation by PINK1 were performed as previously described (2) . Halo-tag-4× UBA UBQLN1 resin was prepared as described by Emmerich et al. (5) (plasmid was a generous gift from P. Cohen, University of Dundee, Dundee, UK) with the following modifications: a 6His-tag was added N-terminal to the Halo-tag; upon expression in Rosetta (DE3) E. coli cells, it was purified by nickel-nitrilotriacetic acid (Ni-NTA) and stored at −80°C. Covalent coupling of Halo-4× UBA UBQLN1 to the resin was done by mixing 5 mg of purified Halo-4× UBA UBQLN1 to 1 mL of HaloLink resin (Promega). DNA encoding for 5× UBA Dsk2 (6) was codon-optimized for E. coli expression (Invitrogen) and subcloned by Gibson cloning into a modified pFN18A vector (6His-HALO) for bacterial expression. 6His-Halo-tag-5× UBA Dsk2 resin was expressed, purified, and prepared in the same way as the Halo-tag-4× UBA UBQLN1 resin. UB mutants (S65A, S65D, and S65E) were expressed and purified as previously described (2) .
Human DNA encoding for OPTN, p62 (SQSTM1), and NDP52 (CALCOCO2) was subcloned into a pDEST-60 vector encoding for N-terminal GST-tag. GST-OPTN, GST-p62, and GST-NDP52 were produced in Rosetta (DE3) E. coli cells and purified by chromatography on glutathione-Sepharose and eluted with 20 mM reduced glutathione in 20 mM Tris·HCl, 150 mM NaCl, and 2 mM DTT (pH 7.5).
Human GST-MIRO1 180-581 was grown at 37°C to an OD 600 of 0.8, induced with 0.6 μM isopropyl-β-D-thiogalactopyranoside (IPTG) for 17 h at 18°C. Pellets were lysed in 50 mM Tris (pH 8.0), 200 mM NaCl, and 5 mM DTT and then affinity-purified on a glutathione-Sepharose column and eluted with 50 mM Tris (pH 8.0), 200 mM NaCl, 5 mM DTT, and 10 mM reduced glutathione. Pooled fractions were further purified by ion exchange and size exclusion chromatography into a final buffer of 25 mM Tris (pH 7.6), 200 mM NaCl, and 1 mM DTT.
All purified proteins used in experiments were run on SDS/ PAGE, followed by staining with Colloidal Coomassie Blue for quality control and phosphorylation stoichiometry measured by MS.
Preparation of Phosphorylated UB. Human UB was phosphorylated in vitro with Tribolium castaneum PINK1 and purified away from PINK1 as previously described (2) . In some experiments, prephosphorylated UB was prepared using a suppressor tRNA system in bacteria, allowing for direct incorporation of phosphoserine at a desired residue (7, 8) . Briefly, human UB DNA encoding for UB fused to a 6× His C-terminal tag was mutated by PCR to replace the Ser codon of interest (S20, S57, or S65) with an Amber stop codon (TAG), which is used for phosphoserine incorporation. UB6His constructs of interest were then subcloned in the pCRT7-NT-Topo-tetR/pLtetO Amp vector (52053; Addgene) by Gibson assembly. EcAR7 strains (52055; Addgene) were cotransformed with the pCRT7 plasmid of interest and pKD-SepRS-EFSep-5× tRNASep (B40 OTS) plasmid (52054; Addgene). After transformation, 0.5 mL of super optimal broth (SOC) medium was added to the bacteria, which were left to recover for 2 h at 30°C. After recovery, transformed EcAR7 strains were plated on an LB agar plate containing both carbenicillin (200 μg/mL) and kanamycin (50 μg/mL), and left to grow at 30°C for the next 2-3 d. Colonies of transformed EcAR7 + B40 OTS + pCRT7 pLtetO/tetR were picked and grown at 30°C in 5 mL (for a few hours) and then in 50 mL of LB supplemented with 0.08% glucose, carbenicillin (200 μg/mL), and kanamycin (50 μg/mL). On the next day, starter cultures were diluted into 2 L of media (LB supplemented with carbenicillin, kanamycin, 2 mM phosphoserine, 0.08% glucose) to an OD 600 of ∼0.1 and grown at 30°C with shaking until the OD 600 reached ∼0.8. Protein expression was started by the addition to final concentration of 1 mM IPTG and 100 ng/mL anhydrotetracycline, and the temperature was lowered to 25°C for the duration of the protein expression procedure (∼24 h). The cells were collected and lysed in 50 mM Tris (pH 7.5), 250 mM NaCl, 1% Triton X-100, 15 mM imidazole, 0.5 mM TCEP, and 1 mM AEBSF. UB-6His WT and mutants were purified by Ni-NTA as previously described (2) . Purified UB-6His was loaded on a gel filtration Superdex 75 10/300 GL system (GE Healthcare).
Analytical Size Exclusion Chromatography. To generate UBCH7-UB iso , 150 μM UBCH7 active site C86K mutant, 450 μM His-UB, and 15 μM Uba1 were incubated for 20 h at 37°C in 30 mM Tris (pH 8.8), 50 mM NaCl, 5 mM ATP, and 10 mM MgCl 2 . The isopeptide-linked UBCH7-UB iso was purified by size exclusion chromatography in 25 mM Tris (pH 7.6), 150 mM NaCl, and 1 mM DTT.
For analytical size exclusion chromatography, all proteins were diluted to 10 μM (20 μM for p-S65-UB) in sizing buffer for at least 30 min on ice before loading onto the column. Fractions were run on SDS/PAGE gels and visualized with Ruby Sypro dye.
In Vitro Ubiquitylation Analysis and UB-AQUA Proteomics. All in vitro ubiquitylation reactions were performed as described previously (2) . Briefly, E1 (0.1 μM UBE1), E2 conjugating enzyme (1 μM UBE2L3), E3 ligase (1 μM PARKIN, unless stated otherwise), and total UB (30 μM, unless stated otherwise) were incubated for the indicated time at 30°C in a 25-μL reaction mixture containing 50 mM Tris·HCl (pH 7.5), 5 mM MgCl 2 , and 0.2 mM TCEP. The reaction was started by the addition of 2 mM ATP and terminated by the addition of SDS sample buffer containing 10 mM EDTA when analyzed on lithium dodecyl sulfate (LDS)/ PAGE or by the addition of 10 mM EDTA and TCA (20% final concentration) precipitated when the reaction was further analyzed by MS (UB-AQUA/PRM Proteomics). In some experiments, GST-MIRO 180-581 was used as a substrate and detected by Western blot analysis using α-GST antibodies.
di-Gly Proteomics. A total of 1.75 mg of purified mitochondria per condition was incubated with 40 μL of HALO-4× UBA UBQLN1 beads for 16 h to capture all chain linkages present in the sample (as well as some monoubiquitin upon long incubation). After incubation beads were spun down at low speed, supernatant was kept and set apart while beads were washed three times with 5 mL of lysis buffer followed by two washes with lysis buffer supplemented with 500 mM NaCl and, finally, five washes with 10 mM Tris (pH 8.0). Supernatant (after HALO-4× UBA UBQLN1 pull-down) was then incubated for 4 h with 15 μL of HALO-5× UBA DSK2 beads to capture residual monoubiquitylated protein left. HALO-5× UBA DSK2 beads were then washed as described before and combined with the HALO-4× UBA UBQLN1 beads, bound proteins were eluted from beads twice by the addition of 150 μL of 6 M guanidine HCL, and eluate was then spun down through a spin-X centrifuge tube filter (0.45 μm). Samples were subjected to reduction (10 mM TCEP) and alkylation (20 mM chloroacetamide) followed by TCA precipitation (20% final). Samples were digested at 37°C first for 4 h with Lys-C alone (in 100 mM TEAB, 0.1% Rapigest, 10% ACN), and trypsin was then added to samples and digested for a further 16 h at 37°C. Digests were acidified with an equal volume of 5% FA to a pH of ∼2 for 30 min, dried down, resuspended in 5% FA, subjected to C18 StageTip desalting, and dried down again.
For enrichment of di-Gly peptides, anti-K-e-GG antibody (Cell Signaling Technology) was used. Before enrichment, the antibody was cross-linked to protein A beads using dimethyl pimelimidate (DMP). Briefly, the beads were washed three times with 1 mL of PBS, and antibody was added to the beads at a 1:1 ratio [micrograms to microliters (pack beads)] and incubated for 30 min in 1 mL of PBS. Beads were then washed four times with 10 vol of 0.1 M sodium borate (pH 9) and then resuspended in 10 vol of 0.1 M sodium borate (pH 9) containing freshly added DMP to a concentration of 20 mM and incubated for 30 min at room temperature with gentle mixing. The beads were pelleted, and this incubation with DMP was repeated. The beads were then washed three times with 10 vol of 50 mM glycine (pH 2.5) to remove all of the antibodies that were not covalently coupled to the beads. The covalently coupled antibody beads were washed once with 0.2 M Tris·HCl (pH 8) and then incubated in this buffer for a further 1 h at room temperature with gentle mixing to ensure that any residual DMP was broken down following reaction with the amine group of Tris. After blocking, the antibody-coupled beads were stored in PBS at 4°C for future use.
Dried peptide was resuspended in 1.25 mL of di-Gly buffer [100 mM Hepes (pH 7.5), 10 mM Na 2 HPO 4 , 50 mM NaCl] and incubated with 7.5 μL (∼7.5 μg of antibody) of cross-linked anti-K-e-GG antibody beads for 6 h on a rotating unit at 4°C. Antibody beads were washed twice with 1.5 mL of ice-cold di-GLY buffer containing 200 mM NaCl and 0.25% Nonidet P-40, twice with di-GLY buffer containing 150 mM NaCl, and three times with PBS. The final wash was in 1 mL of ddH 2 O. di-Gly peptides were eluted twice by adding 20 μL of 0.15% TFA. Peptide supernatants were dried down and desalted using C18 StageTips, and eluted peptides were dried down and resuspended in 5% FA before MS analysis.
MS data were collected using an Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific) coupled to a Proxeon EASYnLC II LC pump (Thermo Fisher Scientific). Peptides were fractionated on a 100-μm i.d. microcapillary column packed with ∼0.5 cm of Magic C4 resin (5 μm, 100 Å; Michrom Bioresources) followed by ∼35 cm of GP-18 resin (1.8 μm, 200 Å; Sepax). Peptides were separated using a 2-h gradient of 4-27% acetonitrile in 0.125% FA at a flow rate of ∼375 nL·min SEQUEST-based identification using a human UniProt database followed by a target decoy-based linear discriminant analysis was used for peptide and protein identification as described (9-11). Parameters used for database searching include the following: 20-ppm precursor mass tolerance, 0.03-Da product ion mass tolerance, and tryptic digestion with up to three missed cleavages. Carboxyamidomethylation of Cys was set as a fixed modification, whereas oxidation of Met and di-Gly modification of Lys were set as variable modifications. Localization of di-Gly sites used a modified version of the A-score algorithm (12) as described (9) . A-scores of 13 were considered localized. Quantification of di-Gly sites based on spectral counts was done as described (9) .
Single-Turnover Assays. For pulse-chase assays, 10 μM UBCH7 was mixed with 0.2 μM UBA1 and 15 μM UB F , where all Lys in UB has been replaced with Arg and has been labeled with fluorescein (UB F ) in reaction buffer containing 50 mM Hepes (pH 7.0), 2.5 mM MgCl 2 , 1.5 mM ATP, and 100 mM NaCl. The loading reaction proceeded for 15 min at room temperature before being quenched in 50 mM Tris (pH 7.6), 50 mM NaCl, and 50 mM EDTA for 5 min on ice. p-WT or p-C431S PARKIN at 0.4 μM was mixed with 0.2-0.4 μM p-UB in a final reaction volume of 50 μL in 25 mM Tris (pH 7.6), 50 mM NaCl, and 50 mM EDTA. The chase reactions were initiated by addition of UBCH7∼UB F and quenched at the indicated time points in SDS sample loading buffer. The di-UB synthesis assays contained 300 μM unlabeled UB WT in the final reaction. GST-hMIRO1 180-581 ubiquitylation reactions contained MIRO at a final concentration of 0.6 μM in the chase reaction.
Capture of UB Chains by Poly-UB Binding Proteins. GST-tagged proteins (3 μg) were immobilized on glutathione-Sepharose [10 μL of packed beads equilibrated in 25 mM Hepes (pH 7.5), 1 mM EGTA, 2 mM MgCl 2 , 0.5% (vol/vol) Triton X-100] plus 150 mM NaCl and incubated for 20 min at 4°C with 0.5 mL of the same buffer. The beads were washed three times and then incubated with gentle agitation for 1 h at 20°C with 0.5 mL of poly-UB chains (2 μg) in the same buffer. The beads were washed five times with buffer plus 150 mM NaCl and once with buffer without NaCl and Triton X-100. Bound proteins were released by denaturation with 2% LDS; the beads were removed by centrifugation for 1 min at 2,000 × g; the supernatants were heated for 5 min at 70°C, subjected to SDS/PAGE, and transferred to PVDF membranes; and proteins were detected by immunoblotting. . The indicated UB-replacement cells stably expressing GFP-PARKIN C431S were depolarized for 1 h, and whole-cell extracts were probed with α-GFP to detect GFP-PARKIN C431S and its lower mobility oxy-ester (oxy) form. (I) Total abundance of UB (K63 locus), K63 linkage, and p-S65-UB in total mitochondria purified from the indicated U2OS cells 1 h after depolarization was determined using a UB-AQUA/PRM method. The number of femtomoles of the indicated species are shown. Error bars represent triplicate measurements (±SEM). (J) Mitochondria were isolated from the indicated cells, ubiquitylated proteins were isolated with HALO-UBA UBQLN1 and HALO-UBA DSK2 , proteins were digested with trypsin, and di-GLY-containing peptides were isolated using α-di-GLY antibodies before analysis by LC-tandem MS. The numbers of spectral counts identified for all MOM proteins identified in this analysis are shown (Dataset S1). -, and UB K63R -replacement cells grown with or without DOX for 5 d were subjected to UB capture using HALO-UBA
UBQLN1
, and bound proteins were analyzed by immunoblotting using α-MFN2 and α-CISD1. This experiment was performed in parallel with the experiment shown in B. WT 20 h after depolarization (n > 100). Error bars represent triplicate measurements (±SEM). GST-OPTN (E), GST-NDP52 (F), or GST-p62 (G) from bacteria was incubated with the indicated forms of UB in binding buffer and washed extensively, and the associated proteins were subjected to immunoblotting with α-UB antibodies. (H) Quantification of the extent of phosphorylation of K48 and K63 chains (Left) and immunoblot validation (Right) used in E-G. Note that the detection of K63 chains modified by phosphorylation of S65 is much weaker than detection of phosphorylated K48 chains. (I) Possible cross-reactivity of p-S65-UB antibody with p-S65-PARKIN or p-S57-UB was examined by immunoblotting of phosphorylated recombinant proteins (100 ng per lane; ∼12 pmol of UB and 2 pmol of PARKIN).
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Fig . S4 . Activation of UB transfer from PARKIN to substrates by p-S65-UB binding. WT, p-S20, p-S57, p-S65-UB, and p-S65-UB I44A were produced using a genetically encoded E. coli system for production of phosphoserine-containing proteins (B) and used at 5 μM in UB chain assembly reactions with unphosphorylated PARKIN (1 μM) in the presence of ATP, E1, UBCH7, and UB (20 μM) (A). p-WT and p-C431S PARKIN were used as positive and negative controls, respectively. Reactions were analyzed by immunoblotting with α-UB antibodies. (C) Quantification of stimulation of p-WT PARKIN catalytic activity by p-S65-UB-6His using UB-AQUA. Error bars represent triplicate measurements (±SEM). (D) p-S65-UB greatly stimulates transfer of Lys-free UB from UBCH7 to PARKIN in single-turnover assays. UBCH7 was charged with E1, UB detected. Loss of UBCH7∼UB F was plotted. Related to Fig. 4B . (E) For single-turnover reactions to examine PARKIN auto-ubiquitylation, UBCH7 was charged with E1, UB F , and ATP, and purified by gel filtration. UBCH7∼UB F was mixed with the indicated PARKIN protein in the presence or absence of p-S65-UB, and reactions were quenched at the indicated times postmixing. Reaction mixtures were separated by SDS/PAGE, and UB F was detected. (F) For single-turnover reactions to examine PARKIN auto-ubiquitylation, UBCH7 or UBCH7
F63A
, which has a mutation in the canonical RING-binding residue (13) , was charged with E1, UB F , and ATP, and purified by gel filtration. UBCH7∼UB F or the indicated mutant was mixed with p-WT PARKIN protein in the presence of p-S65-UB, and reactions were quenched at the indicated times postmixing. Reaction mixtures were separated by SDS/PAGE, and UB F was detected. (G) Enhancement of UBCH7∼UB F discharge by increasing p-WT PARKIN. The indicated concentrations of p-WT PARKIN were incubated with UBCH7∼UB F for the indicated periods of time. Reaction mixtures were separated by SDS/PAGE, and UB F was detected. (H) p-S65-UB promotes transfer of Lys-free UB from UBCH7 to GST-MIRO in a single-turnover assay. As in D, with or without inclusion of GST-MIRO 180-581 . (I) Binding of p-S65-UB to phosphorylated PARKIN C431S promotes association with UBCH7-UB iso (isopeptide-linked). The indicated proteins were mixed and subjected to gel filtration. The levels of free UBCH7-UB iso are reduced in the presence of p-S65-UB. mAu, milli-absorbance units. (J) Analysis of the abundance of p-S65-UB in the steady-state pool of free (monomeric) UB within PINK1 +/+ or PINK1 −/− HeLa cells expressing WT or C431S (C/S) PARKIN 1 h after depolarization. Activation of the PINK1/PARKIN pathway was measured by immunoblotting for MFN2 and CISD1. (Left) PCNA was used as a loading control. (Right) Monomeric pool of UB was isolated as described in SI Materials and Methods, and the abundance of total UB and p-S65-UB was measured using UB-AQUA/PRM (Materials and Methods). Error bars represent triplicate measurements (±SEM).
Dataset S1. List of primary di-GLY sites found on mitochondrial proteins in U2OS replacement cells Dataset S1
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